TB-500 Dosage

TB-500 is a synthetic peptide that exhibits a variety of beneficial properties, including anti-inflammatory effects, enhanced muscle and tendon recovery, and stimulation of wound healing. Additionally, the peptide stimulates angiogenesis and improves body flexibility, making it a key compound in the development of regenerative and aesthetic medicine. TB-500 promotes cardiovascular health, helping to repair blood vessels and improve circulation. Its most common application is in the treatment of chronic and acute inflammatory conditions, traumatic injuries to bones, tendons, and ligaments, as well as tissue regeneration, most often in the context of wound healing.
Dosage Chart
|
Timeline |
Starting dose (one to six weeks) |
Maintenance dose (after six weeks) |
|
A Protocol for treating injuries to regenerate connective tissues |
2 – 5mg (one subcutaneous injection per week) |
2 – 5mg (one subcutaneous injection every two to four weeks) |
About the Peptide
TB-500 is a synthetic peptide designed to mimic the function of the natural peptide Thymosin Beta-4. It consists of thirty-four amino acids and has a wide range of applications. Its most important effect is anti-inflammatory, which makes it potent in treating various inflammatory conditions, both acute and chronic.
Additionally, it is often used for regenerative purposes, particularly in traumatic injuries, where it can accelerate wound healing and promote tissue repair and flexibility. It is highly beneficial for the cardiovascular system’s health, as it can accelerate recovery after a myocardial infarction, while also stimulating angiogenesis (the process of creating new blood vessels) and repairing damaged blood vessels.
The anti-inflammatory property is one of the most significant effects, helping to combat various diseases. Scientists assume that the mechanism of action involves the stimulation of anti-inflammatory cytokines (IL-4, IL-10), along with a simultaneous reduction in the levels of pro-inflammatory cytokines (IL-6, IL-1β, TNF-α). Additionally, a crucial effect in this field is the anti-fibrotic effect. Fibrosis represents a chronic inflammatory process that results in the formation of scar tissue. TB-500 protects lung, tendon, and heart tissues from excessive fibrotic reactions, which is crucial because once the fibrous tissue is replaced by scar tissue, the function is lost in that place.
When it comes to regeneration, this peptide plays a key role. Scientists assume that TB-500 can stimulate cell migration directly to the injury zone where regeneration is needed. In this way, fibroblasts (the primary cells of connective tissue), myoblasts, and endothelial cells quickly arrive at the site of interest. This effect is crucial because during regeneration, damaged tissue is replaced with functionally correct tissue, while during repair, damaged tissue is replaced with an inactive form that does not participate in the function of that organ. Additionally, this peptide can stimulate collagen synthesis and significantly accelerate the wound-healing process. This effect is essential in traumatic injuries and postoperative recovery.
Another crucial property of this peptide is its effect on cardiovascular health. Scientific studies have shown that due to its regenerative effect, it can reduce the size of the scar that occurs after a myocardial infarction and accelerate recovery from this medical condition. Additionally, it supports the migration and proliferation of endothelial cells, thereby contributing to the recovery of damaged blood vessels and enhancing their elasticity.
TB-500 can stimulate VEGF (vascular endothelial growth factor), which leads to angiogenesis (the process of creating new blood vessels). This effect is crucial in ischemic conditions, when circulation is compromised, and it is necessary to restore blood flow to the heart urgently.

List of Uses
Treatment of Acute and Chronic Inflammatory Conditions
There are numerous inflammatory conditions, which are categorized into acute and chronic. The acute form is characterized by symptoms such as redness, pain, fever, and swelling in the affected region. When they become chronic, these conditions lose their symptoms, the tissue loses function, and becomes permanently altered. Scientists assume that TB-500 can have a beneficial effect on both groups of inflammatory conditions.
The mechanisms of action differ, but their basis is a decrease in the levels of pro-inflammatory cytokines (IL-6, IL-1β, TNF-α) and an increase in the levels of anti-inflammatory cytokines (IL-4, IL-10). In addition, the peptide can stimulate macrophages with phagocytic ability to internalize and destroy the cause of inflammation, thereby enhancing the body's immune response. Macrophages that were previously pro-inflammatory under the action of the peptide become regenerative.
According to the results of scientific studies, it has been found that the peptide can reduce oxidative stress by decreasing the production of reactive oxygen species (ROS). In this way, the immune response is further enhanced, and cell survival is reduced. By stabilizing the cell membrane, the peptide prevents the spread of the process to the surrounding structure, which is a widespread mechanism of infection. Thanks to this criterion, the peptide can be used in treating various autoimmune inflammatory diseases such as rheumatoid arthritis.
Regeneration of Connective Tissues
TB-500 is a potent peptide for tissue regeneration. This applies to all types of damage, but especially to traumatic injuries. Scientists believe that the crucial step that the peptide enables is the synthesis of Actin (a protein that moves the cell). In this way, primary and secondary cells of the immune system, as well as other cells (such as fibroblasts and stem cells), immediately arrive at the site of repair and initiate the repair process.
In the case of myocardial infarction, when there is insufficient perfusion of the heart and compromised circulation, the part of the heart that does not receive enough blood becomes replaced by scar tissue. This part of the organ is permanently non-functional, which significantly complicates the patient's recovery and further life. Instead, the peptide promotes regeneration (replacement of damaged heart muscle with new functional tissue). If the extent of damage is significant, TB-500 will undoubtedly reduce the size of the scar tissue.
Another key effect in tissue regeneration is the stimulation of stem cell maturation. These cells are newly created, young, and undifferentiated. The body uses these cells in cases where it is urgently necessary to increase the level of some cells that are in short supply.
Improving Cardiovascular Health
In addition to reducing inflammation, promoting heart muscle regeneration after myocardial infarction, and reducing scar size, TB-500 may also improve cardiovascular health in several ways. One of these involves protecting cardiomyocytes by decreasing the expression of anti-apoptotic proteins, thereby reducing oxidative stress and enhancing cardiac function.
In addition to protecting the heart muscle, this peptide has numerous beneficial effects on blood vessels. In the event of damage resulting from a blood vessel rupture, blockage, bleeding, or traumatic injury, the peptide accelerates the repair process through its regenerative properties. The function of the blood vessel is fully restored, and the formation of new blood vessels and collateral blood flow is stimulated. This effect is crucial in the case of a blocked blood vessel, because then other blood vessels will take over its role and reduce the size of the leak.
Dosing Calculator
The optimal dose and method of dosing, as always, vary depending on the indication. If the peptide is used to treat traumatic injuries and other tissue damage, aiming to regenerate connective tissue and restore functionality, the optimal dose in the first weeks is 2-5 mg. It is administered as a single subcutaneous injection once or twice a week. The region of interest is the abdomen or another region rich in fatty tissue.
After the first week, a maintenance dose of 2-5mg is administered once every two to four weeks. The maximum recommended dose should never be exceeded or changed independently to avoid the occurrence of systemic unwanted effects.
Conclusion
When used as directed, TB-500 can exhibit numerous beneficial effects, including faster wound healing, tissue repair and regeneration after injury and damage, anti-inflammatory effects, and improved cardiovascular health. Regardless of its current achievements, TB-500 will undoubtedly be the subject of future research.
References:
- Maar K, Hetenyi R, Maar S, Faskerti G, Hanna D, Lippai B, Takatsy A, Bock-Marquette I. Utilizing Developmentally Essential Secreted Peptides Such as Thymosin Beta-4 to Remind the Adult Organs of Their Embryonic State-New Directions in Anti-Aging Regenerative Therapies. Cells. 2021 May 28;10(6):1343. doi: 10.3390/cells10061343. PMID: 34071596; PMCID: PMC8228050.
- Kleinman HK, Sosne G. Thymosin β4 Promotes Dermal Healing. Vitam Horm. 2016;102:251-75. doi: 10.1016/bs.vh.2016.04.005. Epub 2016 May 24.
- Freeman, K. W., Bowman, B. R., & Zetter, B. R. (2011). Regenerative protein thymosin beta-4 is a novel regulator of purinergic signaling. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 25(3), 907–915. https://doi.org/10.1096/fj.10-169417
- Sosne, G., Qiu, P., & Kurpakus-Wheater, M. (2007). Thymosin beta 4: A novel corneal wound healing and anti-inflammatory agent. Clinical ophthalmology (Auckland, N.Z.), 1(3), 201–207.
- Bock-Marquette, I., Saxena, A., White, M. D., Dimaio, J. M., & Srivastava, D. (2004). Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature, 432(7016), 466–472. https://doi.org/10.1038/nature03000
- Philp D, Goldstein AL, Kleinman HK. Thymosin beta4 promotes angiogenesis, wound healing, and hair follicle development. Mech Ageing Dev. 2004 Feb;125(2):113-5. doi: 10.1016/j.mad.2003.11.005. PMID: 15037013.
- Han HJ, Kim S, Kwon J. Thymosin beta 4-Induced Autophagy Increases Cholinergic Signaling in PrP (106-126)-Treated HT22 Cells. Neurotox Res. 2019 Jul;36(1):58-65. doi: 10.1007/s12640-018-9985-0. Epub 2018 Dec 15. PMID: 30552633.
- Kassem KM, Vaid S, Peng H, Sarkar S, Rhaleb NE. Tβ4-Ac-SDKP pathway: Any relevance for the cardiovascular system? Can J Physiol Pharmacol. 2019 Jul;97(7):589-599. doi: 10.1139/cjpp-2018-0570. Epub 2019 Mar 9. PMID: 30854877; PMCID: PMC6824425.